Definitive Healthcare Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on February 18, 2022, by Definitive Healthcare Corp. (DH), an emerging growth company incorporated in Delaware. The filing primarily reports on a significant acquisition completed on February 18, 2022, and references the upcoming announcement of financial results for the fourth quarter and fiscal year ended December 31, 2021, scheduled for February 23, 2022.
Key Financial Metrics and Transaction Details
The filing details a major acquisition of Analytical Wizards, Inc. ("AW"). The transaction structure includes:
- Acquisition Consideration: $65,000,000 in cash, subject to adjustments for cash, indebtedness, and net working capital.
- Contingent Consideration: Up to $5,000,000 in additional cash payable if specific expense control metrics are met over a two-year period.
- Prior Investment: On December 22, 2021, the Company invested $35,000,000 in AW for Series B Preferred Stock, representing approximately 35% of AW's fully-diluted capitalization.
- Ownership Status: Following the acquisition, Definitive Healthcare, LLC owns 100% of AW's equity interests.
Note: This filing does not contain specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company. These metrics are referenced as being contained in the press release dated February 23, 2022 (Exhibit 99.1), which is incorporated by reference but not detailed in the text of this 8-K.
Material Changes
The primary material change is the expansion of the Company's portfolio through the 100% acquisition of Analytical Wizards, Inc. This follows a strategic minority investment made in late 2021. The filing does not provide comparative financial data or year-over-year changes in operating metrics.
Outlook, Risks, and Contingencies
Contingencies: The total consideration for the AW acquisition is contingent upon the target meeting specific expense control metrics over the next two years, which could result in an additional $5,000,000 payout.
Management Commentary: The filing indicates that the Company will issue a press release on February 23, 2022, detailing its financial results for the fourth quarter and full year 2021. No specific guidance or forward-looking statements regarding future revenue or earnings are included in this specific document text.
Key Facts for Investor Verification
- Verify the final purchase price of Analytical Wizards, Inc. after working capital and debt adjustments.
- Review the February 23, 2022 press release (Exhibit 99.1) for Q4 and FY 2021 revenue, net income, and cash flow figures.
- Assess the impact of the $65 million cash outlay on the Company's current liquidity and debt covenants.
- Monitor the achievement of the expense control metrics required to trigger the $5 million contingent payment.
- Confirm the integration strategy for Analytical Wizards, Inc. into Definitive Healthcare's existing operations.